{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:46:26Z","timestamp":1790135186464,"version":"4.0.1"},"reference-count":176,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["217357\/Z\/19\/Z"],"award-info":[{"award-number":["217357\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["217357\/Z\/19\/Z"],"award-info":[{"award-number":["217357\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ivermectin is a broad-spectrum antiparasitic agent that interferes with glutamate-gated chloride channels found in invertebrates but not in vertebrate species. Mass drug administration (MDA) with ivermectin-based regimes has been a mainstay of elimination efforts targeting onchocerciasis and lymphatic filariasis for more than 3\u00a0decades. More recently, interest in the use of ivermectin to control other neglected tropical diseases (NTDs) such as soil-transmitted helminths and scabies has grown. Interest has been further stimulated by the fact that ivermectin displays endectocidal efficacy against various Anopheles species capable of transmitting malaria. Therefore there is growing interest in using ivermectin MDA as a tool that might aid in the control of both malaria and several NTDs. In this review we outline the evidence base to date on these emerging indications for ivermectin MDA with reference to clinical and public health data and discuss the rationale for evaluating the range of impacts of a malaria ivermectin MDA on other NTDs.<\/jats:p>","DOI":"10.1093\/trstmh\/trab114","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T11:12:01Z","timestamp":1626261121000},"page":"201-212","source":"Crossref","is-referenced-by-count":14,"title":["Broadening the range of use cases for ivermectin \u2013 a review of the evidence"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-9760","authenticated-orcid":false,"given":"Christian","family":"Kositz","sequence":"first","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E\u00a07HT, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[{"name":"MRC International Statistics and Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E\u00a07HT, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hutchins","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E\u00a07HT, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Last","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E\u00a07HT, London, UK"},{"name":"Hospital for Tropical Diseases, Mortimer Market Capper Street, WC1E\u00a06JB, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D'Alessandro","sequence":"additional","affiliation":[{"name":"Disease Control and Elimination, Medical Research Council Unit Gambia at London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E\u00a07HT, London, UK"},{"name":"Hospital for Tropical Diseases, Mortimer Market Capper Street, WC1E\u00a06JB, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"issue":"12","key":"2022030221285293700_bib1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nrmicro1048","article-title":"The life and times of ivermectin\u2014a success story","volume":"2","author":"Omura","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"1\u20132","key":"2022030221285293700_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetpar.2013.12.021","article-title":"Herding the U.S. cattle industry toward a paradigm shift in parasite control","volume":"204","author":"McArthur","year":"2014","journal-title":"Vet Parasitol"},{"issue":"2\u20134","key":"2022030221285293700_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vetpar.2012.04.009","article-title":"A survey of the trichostrongylid nematode species present on UK sheep farms and associated anthelmintic control practices","volume":"189","author":"Burgess","year":"2012","journal-title":"Vet Parasitol"},{"issue":"10","key":"2022030221285293700_bib4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/jm00184a014","article-title":"Ivermectin, a new broad-spectrum antiparasitic agent","volume":"23","author":"Chabala","year":"1980","journal-title":"J Med Chem"},{"issue":"4","key":"2022030221285293700_bib5","first-page":"331","article-title":"Comparison of ivermectin and benzyl benzoate for treatment of scabies","volume":"44","author":"Glaziou","year":"1993","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"2022030221285293700_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0169-4758(93)90210-7","article-title":"Avermectins in arthropod vector management\u2014prospects and pitfalls","volume":"9","author":"Wilson","year":"1993","journal-title":"Parasitol Today"},{"issue":"2","key":"2022030221285293700_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0035-9203(91)90037-Y","article-title":"A field study of the effect of ivermectin on intestinal helminths in man","volume":"85","author":"Whitworth","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022030221285293700_bib8","first-page":"416","article-title":"Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites","volume":"54(7)","author":"Heukelbach","year":"2011","journal-title":"Arzneimittelforschung"},{"issue":"24","key":"2022030221285293700_bib9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"2022030221285293700_bib10","doi-asserted-by":"crossref","first-page":"e0004151","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian aboriginal community","volume":"9","author":"Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"2022030221285293700_bib11","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/cid\/ciaa584","article-title":"Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022030221285293700_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12936-017-1801-4","article-title":"Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety","volume":"16","author":"Chaccour","year":"2017","journal-title":"Malar J"},{"key":"2022030221285293700_bib13","first-page":"571","article-title":"Mode of action of avermectin","volume-title":"Macrolide antibiotics: chemistry, biology and practice","author":"Omura","year":"2002"},{"issue":"10","key":"2022030221285293700_bib14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1242\/jeb.118570","article-title":"Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae","volume":"218","author":"Meyers","year":"2015","journal-title":"J Exp Biol"},{"issue":"6","key":"2022030221285293700_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","article-title":"Ivermectin \u2013 old drug, new tricks?","volume":"33","author":"Laing","year":"2017","journal-title":"Trends Parasitol"},{"issue":"Suppl 1","key":"2022030221285293700_bib16","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2883-2-S1-S8","article-title":"Ivermectin: does P-glycoprotein play a role in neurotoxicity?","volume":"2","author":"Edwards","year":"2003","journal-title":"Filaria J"},{"key":"2022030221285293700_bib17","first-page":"317","article-title":"The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug","volume":"8(2)","author":"Juarez","year":"2018","journal-title":"Am J Cancer Res"},{"issue":"8","key":"2022030221285293700_bib18","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2022030221285293700_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41429-020-0336-z","article-title":"Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen","volume":"73","author":"Heidary","year":"2020","journal-title":"J Antibiot (Tokyo)"},{"issue":"Suppl 1","key":"2022030221285293700_bib20","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1017\/S0031182005008218","article-title":"Glutamate-gated chloride channels and the mode of action of the avermectin\/milbemycin anthelmintics","volume":"131","author":"Wolstenholme","year":"2006","journal-title":"Parasitology"},{"issue":"4","key":"2022030221285293700_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"issue":"8","key":"2022030221285293700_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMc1917344","article-title":"Serious ivermectin toxicity and human ABCB1 nonsense mutations","volume":"383","author":"Baudou","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"2022030221285293700_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"12","key":"2022030221285293700_bib24","first-page":"1165","article-title":"Pharmacogenetics: it's not just about ivermectin in collies","volume":"47","author":"Dowling","year":"2006","journal-title":"Can Vet J"},{"key":"2022030221285293700_bib25","journal-title":"Mectizan Donation Program"},{"issue":"10","key":"2022030221285293700_bib26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"2022030221285293700_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Smit","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2022030221285293700_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cpt.1219","article-title":"Pharmacokinetics-pharmacodynamics of high-dose ivermectin with dihydroartemisinin-piperaquine on mosquitocidal activity and QT-prolongation (IVERMAL)","volume":"105","author":"Smit","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2022030221285293700_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2003.10.018","article-title":"Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly","volume":"98","author":"Kamgno","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"2022030221285293700_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0035-9203(99)90305-X","article-title":"The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients","volume":"93","author":"Awadzi","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022030221285293700_bib31","first-page":"131","article-title":"The chemotherapy of onchocerciasis. XIX: the clinical and laboratory tolerance of high dose ivermectin","volume":"46(2)","author":"Awadzi","year":"1995","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"2022030221285293700_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0035-9203(02)90112-4","article-title":"Efficacy of repeated doses of ivermectin against Mansonella perstans","volume":"96","author":"Gardon","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"2022030221285293700_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4269\/ajtmh.2008.78.546","article-title":"Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp","volume":"78","author":"Kamgno","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"2022030221285293700_bib34","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2883-2-S1-S4","article-title":"Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003","journal-title":"Filaria J"},{"issue":"1","key":"2022030221285293700_bib35","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"12","key":"2022030221285293700_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1360-2276.2003.01142.x","article-title":"Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis","volume":"8","author":"Gyapong","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"4","key":"2022030221285293700_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod Toxicol"},{"key":"2022030221285293700_bib38","volume-title":"Package insert","author":"Merck & Co. Stromectrol (Ivermectin)"},{"key":"2022030221285293700_bib39","volume-title":"Center for Drug Evaluation and Research","author":"Food and Drug Administration"},{"key":"2022030221285293700_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-3626-9","volume-title":"Ivermectin and abamectin","author":"Campbell","year":"1989"},{"key":"2022030221285293700_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fnins.2014.00404","article-title":"The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history","volume":"8","author":"Saunders","year":"2014","journal-title":"Front Neurosci"},{"issue":"3","key":"2022030221285293700_bib42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuro.2011.12.009","article-title":"Barriers in the developing brain and neurotoxicology","volume":"33","author":"Ek","year":"2012","journal-title":"NeuroToxicology"},{"issue":"4","key":"2022030221285293700_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/pr.2015.119","article-title":"The ontogeny of P-glycoprotein in the developing human blood\u2013brain barrier: implication for opioid toxicity in neonates","volume":"78","author":"Lam","year":"2015","journal-title":"Pediatr Res"},{"issue":"4","key":"2022030221285293700_bib44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.18369","article-title":"Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study","volume":"182","author":"Levy","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"2022030221285293700_bib45","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/bjd.18685","article-title":"Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes","volume":"182","author":"Colebunders","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"2022030221285293700_bib46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.18788","article-title":"Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies","volume":"182","author":"Morris-Jones","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"2022030221285293700_bib47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Question 1: is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?","volume":"103","author":"Wilkins","year":"2018","journal-title":"Arch Dis Child"},{"issue":"2","key":"2022030221285293700_bib48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.arcped.2015.11.002","article-title":"Tol\u00e9rance de l'ivermectine orale chez l'enfant","volume":"23","author":"Chosidow","year":"2016","journal-title":"Arch P\u00e9diatrie"},{"issue":"3","key":"2022030221285293700_bib49","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cpt.1456","article-title":"Ivermectin dosing strategy to achieve equivalent exposure coverage in children and adults","volume":"106","author":"Brussee","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2022030221285293700_bib50","doi-asserted-by":"crossref","first-page":"e0009144","DOI":"10.1371\/journal.pntd.0009144","article-title":"A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication?","volume":"15","author":"Jittamala","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2022030221285293700_bib51","doi-asserted-by":"crossref","DOI":"10.30875\/7e6f8c91-en","volume-title":"World malaria report 2019","author":"World Health Organization","year":"2019"},{"key":"2022030221285293700_bib52","first-page":"790","article-title":"Mosquito behavior change after distribution of bednets results in decreased protection against malaria exposure","volume":"215(5)","author":"Thomsen","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"2022030221285293700_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/mve.12299","article-title":"Studies on the resting behaviour and host choice of Anopheles gambiae and An. arabiensis from Muleba, Tanzania: resting in Anopheles gambiae s.l","volume":"32","author":"Charlwood","year":"2018","journal-title":"Med Vet Entomol"},{"key":"2022030221285293700_bib54","volume-title":"Insecticide resistance","author":"World Health Organization"},{"issue":"3","key":"2022030221285293700_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14787210.2017.1271713","article-title":"Ivermectin: a complimentary weapon against the spread of malaria?","volume":"15","author":"Alout","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2022030221285293700_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1475-2875-12-153","article-title":"Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination","volume":"12","author":"Chaccour","year":"2013","journal-title":"Malar J"},{"issue":"2","key":"2022030221285293700_bib57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1603\/ME11164","article-title":"The effect of ivermectin in seven strains of Aedes aegypti (Diptera: Culicidae) including a genetically diverse laboratory strain and three permethrin resistant strains","volume":"49","author":"Deus","year":"2012","journal-title":"J Med Entomol"},{"issue":"2","key":"2022030221285293700_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2010.06.001","article-title":"The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors","volume":"116","author":"Kobylinski","year":"2010","journal-title":"Acta Trop"},{"issue":"10","key":"2022030221285293700_bib59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1242\/jeb.118596","article-title":"Mosquitocidal properties of IgG targeting the glutamate-gated chloride channel in three mosquito disease vectors (Diptera: Culicidae)","volume":"218","author":"Meyers","year":"2015","journal-title":"J Exp Biol"},{"issue":"2","key":"2022030221285293700_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2915.1999.00159.x","article-title":"Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival","volume":"13","author":"Bockarie","year":"1999","journal-title":"Med Vet Entomol"},{"issue":"6","key":"2022030221285293700_bib61","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1371\/journal.pntd.0000696","article-title":"Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission","volume":"4","author":"Simonsen","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2022030221285293700_bib62","first-page":"400","article-title":"Effects of ivermectin in canine blood on Anopheles quadrimaculatus, Aedes albopictus and Culex salinarius","volume":"9(4)","author":"Gardner","year":"1993","journal-title":"J Am Mosq Control Assoc"},{"issue":"1","key":"2022030221285293700_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"J Infect Dis"},{"key":"2022030221285293700_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12936-016-1540-y","article-title":"Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector","volume":"15","author":"Sampaio","year":"2016","journal-title":"Malar J"},{"key":"2022030221285293700_bib65","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12936-017-2125-0","article-title":"Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malar J"},{"key":"2022030221285293700_bib66","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12936-017-1923-8","article-title":"Ivermectin susceptibility and sporontocidal effect in Greater Mekong subregion Anopheles","volume":"16","author":"Kobylinski","year":"2017","journal-title":"Malar J"},{"key":"2022030221285293700_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12936-018-2296-3","article-title":"Differential susceptibilities of Anopheles albimanus and Anopheles stephensi mosquitoes to ivermectin","volume":"17","author":"Dreyer","year":"2018","journal-title":"Malar J"},{"issue":"3","key":"2022030221285293700_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/trstmh\/trx025","article-title":"Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands","volume":"111","author":"Kositz","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022030221285293700_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1475-2875-9-365","article-title":"Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors","volume":"9","author":"Sylla","year":"2010","journal-title":"Malar J"},{"issue":"7","key":"2022030221285293700_bib70","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/cid\/ciy1063","article-title":"Human direct skin feeding versus membrane feeding to assess the mosquitocidal efficacy of high-dose ivermectin (IVERMAL trial)","volume":"69","author":"Smit","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022030221285293700_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12936-015-0691-6","article-title":"Establishment of the ivermectin research for malaria elimination network: updating the research agenda","volume":"14","author":"Chaccour","year":"2015","journal-title":"Malar J"},{"issue":"4","key":"2022030221285293700_bib72","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","article-title":"Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study","volume":"20","author":"Slater","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2022030221285293700_bib73","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.2196\/resprot.6617","article-title":"Efficacy and safety of high-dose ivermectin for reducing malaria transmission (IVERMAL): protocol for a double-blind, randomized, placebo-controlled, dose-finding trial in western Kenya","volume":"5","author":"Smit","year":"2016","journal-title":"JMIR Res Protoc"},{"issue":"10180","key":"2022030221285293700_bib74","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial","author":"Foy","year":"2019","journal-title":"Lancet"},{"issue":"10203","key":"2022030221285293700_bib75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(19)31663-0","article-title":"Analysis of the RIMDAMAL trial","volume":"394","author":"Bradley","year":"2019","journal-title":"Lancet"},{"issue":"10203","key":"2022030221285293700_bib76","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(19)32139-7","article-title":"Analysis of the RIMDAMAL trial \u2013 authors\u2019 reply","volume":"394","author":"Foy","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"2022030221285293700_bib77","doi-asserted-by":"crossref","first-page":"e20904","DOI":"10.2196\/20904","article-title":"Mass drug administration with high-dose ivermectin and dihydroartemisinin-piperaquine for malaria elimination in an area of low transmission with high coverage of malaria control interventions: protocol for the MASSIV cluster randomized clinical trial","volume":"9","author":"Dabira","year":"2020","journal-title":"JMIR Res Protoc"},{"key":"2022030221285293700_bib78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13071-019-3392-0","article-title":"Treatment of pigs with endectocides as a complementary tool for combating malaria transmission by Anopheles farauti (s.s.) in Papua New Guinea","volume":"12","author":"Pasay","year":"2019","journal-title":"Parasit Vectors"},{"issue":"4","key":"2022030221285293700_bib79","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4269\/ajtmh.2010.10-0242","article-title":"Analysis of Anopheles arabiensis blood feeding behavior in southern Zambia during the two years after introduction of insecticide-treated bed nets","volume":"83","author":"Fornadel","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2022030221285293700_bib80","doi-asserted-by":"crossref","first-page":"40551","DOI":"10.1038\/srep40551","article-title":"Increasing the potential for malaria elimination by targeting zoophilic vectors","volume":"7","author":"Waite","year":"2017","journal-title":"Sci Rep"},{"key":"2022030221285293700_bib81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12936-019-2932-6","article-title":"Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern Belize","volume":"18","author":"Dreyer","year":"2019","journal-title":"Malar J"},{"key":"2022030221285293700_bib82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12936-015-1001-z","article-title":"Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria","volume":"14","author":"Pooda","year":"2015","journal-title":"Malar J"},{"key":"2022030221285293700_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12936-017-1885-x","article-title":"Ivermectin-treated cattle reduces blood digestion, egg production and survival of a free-living population of Anopheles arabiensis under semi-field condition in south-eastern Tanzania","volume":"16","author":"Lyimo","year":"2017","journal-title":"Malar J"},{"issue":"3","key":"2022030221285293700_bib84","doi-asserted-by":"crossref","first-page":"e02104","DOI":"10.1128\/AAC.02104-16","article-title":"Pilot study of a slow-release ivermectin formulation for malaria control in a pig model","volume":"61","author":"Chaccour","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"2022030221285293700_bib85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.vetpar.2007.04.009","article-title":"Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations","volume":"147","author":"Lifschitz","year":"2007","journal-title":"Vet Parasitol"},{"issue":"1","key":"2022030221285293700_bib86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2885.1999.00172.x","article-title":"Bioequivalence of ivermectin formulations in pigs and cattle","volume":"22","author":"Lifschitz","year":"1999","journal-title":"J Vet Pharmacol Ther"},{"key":"2022030221285293700_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-3305-6-165","article-title":"Decrease in survival and fecundity of Glossina palpalis gambiensis vanderplank 1949 (Diptera: Glossinidae) fed on cattle treated with single doses of ivermectin","volume":"6","author":"Pooda","year":"2013","journal-title":"Parasit Vectors"},{"issue":"2","key":"2022030221285293700_bib88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1570-7458.1984.tb03419.x","article-title":"Ivermectin as a possible control agent for the tsetse fly, Glossina morsitans","volume":"36","author":"Langley","year":"1984","journal-title":"Entomol Exp Appl"},{"key":"2022030221285293700_bib89","first-page":"167","article-title":"Efficacy of ivermectin on the reproductive biology of Glossina palpalis palpalis (Rob.-Desv.) (Glossinidae: Diptera)","volume":"66","author":"van den Abbeele","year":"1986","journal-title":"Ann Soc Belg Med Trop"},{"issue":"8","key":"2022030221285293700_bib90","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1590\/S0074-02762005000800002","article-title":"Ticks, ivermectin, and experimental Chagas disease","volume":"100","author":"Dias","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2022030221285293700_bib91","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12936-015-1063-y","article-title":"Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control","volume":"15","author":"Chaccour","year":"2016","journal-title":"Malar J"},{"key":"2022030221285293700_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.19-0620","article-title":"A roadmap for the development of ivermectin as a complementary malaria vector control tool","volume":"102(2 Suppl)","author":"Ivermectin Roadmappers","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"1818","key":"2022030221285293700_bib93","doi-asserted-by":"crossref","first-page":"20190810","DOI":"10.1098\/rstb.2019.0810","article-title":"Veterinary endectocides for malaria control and elimination: prospects and challenges","volume":"376","author":"Chaccour","year":"2021","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"2022030221285293700_bib94","first-page":"492","article-title":"Need for a sustainable use of medicinal products: environmental impacts of ivermectin","volume":"56","author":"Mancini","year":"2020","journal-title":"Ann Ist Super Sanita"},{"issue":"Suppl","key":"2022030221285293700_bib95","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ieam.96","article-title":"Environmental risk assessment of ivermectin: a case study","volume":"6","author":"Liebig","year":"2010","journal-title":"Integr Environ Assess Manag"},{"issue":"1","key":"2022030221285293700_bib96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0007485319000385","article-title":"Toxicological effect of ivermectin on the survival, reproduction, and feeding activity of four species of dung beetles (Coleoptera: Scarabaeidae and Geotrupidae) in Japan","volume":"110","author":"Ishikawa","year":"2020","journal-title":"Bull Entomol Res"},{"key":"2022030221285293700_bib97","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.baae.2019.07.006","article-title":"Effects of herd management and the use of ivermectin on dung arthropod communities in grasslands","volume":"40","author":"Pecenka","year":"2019","journal-title":"Basic Appl Ecol"},{"issue":"1\u20134","key":"2022030221285293700_bib98","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0304-4017(93)90163-H","article-title":"Environmental assessment of avermectins by the US Food and Drug Administration","volume":"48","author":"Bloom","year":"1993","journal-title":"Vet Parasitol"},{"issue":"6","key":"2022030221285293700_bib99","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4269\/ajtmh.19-0915","article-title":"Prevalence of intestinal parasites in a low-income Texas community","volume":"102","author":"Singer","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2022030221285293700_bib100","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4269\/ajtmh.17-0396","article-title":"Human intestinal parasite burden and poor sanitation in rural Alabama","volume":"97","author":"McKenna","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"2022030221285293700_bib101","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N Engl J Med"},{"key":"2022030221285293700_bib102","volume-title":"Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups","year":"2017"},{"issue":"5","key":"2022030221285293700_bib103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","article-title":"A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","author":"Marti","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"2022030221285293700_bib104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.mi.45.100191.002305","article-title":"Ivermectin as an antiparasitic agent for use in humans","volume":"45","author":"Campbell","year":"1991","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"2022030221285293700_bib105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.actatropica.2008.03.007","article-title":"A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China","volume":"106","author":"Wen","year":"2008","journal-title":"Acta Trop"},{"issue":"6","key":"2022030221285293700_bib106","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/infdis\/159.6.1151","article-title":"The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans","volume":"159","author":"Freedman","year":"1989","journal-title":"J Infect Dis"},{"issue":"11","key":"2022030221285293700_bib107","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1473-3099(19)30289-0","article-title":"Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial","volume":"19","author":"Buonfrate","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2022030221285293700_bib108","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pntd.0001044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","author":"Suputtamongkol","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2022030221285293700_bib109","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4269\/ajtmh.1989.40.304","article-title":"Ivermectin for human strongyloidiasis and other intestinal helminths","volume":"40","author":"Naquira","year":"1989","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"2022030221285293700_bib110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/cid\/ciy246","article-title":"Efficacy and safety of ivermectin against Trichuris trichiura in preschool-aged and school-aged children: a randomized controlled dose-finding trial","volume":"67","author":"Wimmersberger","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022030221285293700_bib111","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40475-015-0062-y","article-title":"Human trichuriasis: whipworm genetics, phylogeny, transmission and future research directions","volume":"2","author":"Betson","year":"2015","journal-title":"Curr Trop Med Rep"},{"issue":"5","key":"2022030221285293700_bib112","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/jdv.12097","article-title":"The efficacy of single dose ivermectin in the treatment of hookworm related cutaneous larva migrans varies depending on the clinical presentation","volume":"28","author":"Vanhaecke","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"2022030221285293700_bib113","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/313787","article-title":"Treatment of cutaneous larva migrans","volume":"30","author":"Caumes","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2022030221285293700_bib114","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pntd.0000317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"Ottesen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"2022030221285293700_bib115","volume-title":"Progress Report 2000\u20132009 and Strategic Plan 2010\u20132020 of the Global Programme to Eliminate Lymphatic Filariasis","author":"World Health Organization","year":"2010"},{"key":"2022030221285293700_bib116","volume-title":"Onchocerciasis","author":"World Health Organization"},{"issue":"9","key":"2022030221285293700_bib117","doi-asserted-by":"crossref","first-page":"e1825","DOI":"10.1371\/journal.pntd.0001825","article-title":"Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal","volume":"6","author":"Traore","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2022030221285293700_bib118","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","article-title":"Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis","volume":"8","author":"Bas\u00e1\u00f1ez","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2022030221285293700_bib119","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/cid\/cix616","article-title":"Macrofilaricidal efficacy of repeated doses of ivermectin for the treatment of river blindness","volume":"65","author":"Walker","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2022030221285293700_bib120","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1093\/cid\/ciz1050","article-title":"Efficacy and safety of a single dose of ivermectin, diethylcarbamazine, and albendazole for treatment of lymphatic filariasis in C\u00f4te d'Ivoire: an open-label randomized controlled trial","volume":"71","author":"Bjerum","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2022030221285293700_bib121","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1017\/S0031182000007423","article-title":"An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis","volume":"121","author":"Horton","year":"2000","journal-title":"Parasitology"},{"issue":"3","key":"2022030221285293700_bib122","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/civ882","article-title":"Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis","volume":"62","author":"Thomsen","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2022030221285293700_bib123","doi-asserted-by":"crossref","first-page":"e0008298","DOI":"10.1371\/journal.pntd.0008298","article-title":"Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: results from a two-armed, open-label, cluster-randomized, community study","volume":"14","author":"Dubray","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2022030221285293700_bib124","doi-asserted-by":"crossref","first-page":"e0008106","DOI":"10.1371\/journal.pntd.0008106","article-title":"The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: a cluster randomised trial","volume":"14","author":"Hardy","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2022030221285293700_bib125","doi-asserted-by":"crossref","first-page":"ofz019","DOI":"10.1093\/ofid\/ofz019","article-title":"Effect of a single standard dose (150\u2013200 \u03bcg\/kg) of ivermectin on Loa loa microfilaremia: systematic review and meta-analysis","volume":"6","author":"Pion","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"2022030221285293700_bib126","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0169-4758(96)40006-0","article-title":"Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas","volume":"12","author":"Chippaux","year":"1996","journal-title":"Parasitol Today"},{"issue":"4","key":"2022030221285293700_bib127","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/315014","article-title":"Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin","volume":"180","author":"Fischer","year":"1999","journal-title":"J Infect Dis"},{"key":"2022030221285293700_bib128","first-page":"9","article-title":"Mansonellosis: current perspectives","volume":"9","author":"Ta-Tang","year":"2018","journal-title":"Res Rep Trop Med"},{"issue":"3","key":"2022030221285293700_bib129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4269\/ajtmh.17-0698","article-title":"Phase III clinical trial to evaluate ivermectin in the reduction of Mansonella ozzardi infection in the Brazilian Amazon","volume":"98","author":"de Almeida Basano","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2022030221285293700_bib130","first-page":"1170","article-title":"Sustained clearance of Mansonella ozzardi infection after treatment with ivermectin in the Brazilian Amazon","volume":"90(6)","author":"Medeiros","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2022030221285293700_bib131","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.1988.39.480","article-title":"Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections","volume":"39","author":"Richard-Lenoble","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"2022030221285293700_bib132","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.trstmh.2005.07.009","article-title":"Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis","volume":"100","author":"Bregani","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2022030221285293700_bib133","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0035-9203(93)90438-V","article-title":"Treatment failure of a single high dose of ivermectin for Mansonella perstans filariasis","volume":"87","author":"van den Enden","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"2022030221285293700_bib134","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.trstmh.2008.10.038","article-title":"A randomised, double-blind field trial of ivermectin alone and in combination with albendazole for the treatment of Mansonella perstans infections in Uganda","volume":"103","author":"Asio","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"2022030221285293700_bib135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1179\/000349803225002462","article-title":"Impact of long-term ivermectin (Mectizan\u00ae) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications","volume":"97","author":"Kyelem","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"2022030221285293700_bib136","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1948-7134.2009.00022.x","article-title":"Effects of ivermectin on the susceptibility of Culicoides sonorensis (Diptera: Ceratopogonidae) to bluetongue and epizootic hemorrhagic disease viruses","volume":"34","author":"Reeves","year":"2009","journal-title":"J Vector Ecol"},{"issue":"8","key":"2022030221285293700_bib137","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/v11080731","article-title":"Field evaluation of deltamethrin and ivermectin applications to cattle on culicoides host alighting, blood-feeding, and emergence","volume":"11","author":"Murchie","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"2022030221285293700_bib138","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.00003-09","article-title":"Gnathostomiasis, another emerging imported disease","volume":"22","author":"Herman","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"2022030221285293700_bib139","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4269\/ajtmh.2004.71.623","article-title":"Treatment of cutaneous gnathostomiasis with ivermectin","volume":"71","author":"Kraivichian","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2022030221285293700_bib140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5152\/tpd.2011.22","article-title":"Therapeutic efficacy of dormectin, ivermectin and levamisole against different stages of Trichinella spiralis in rats","volume":"35","author":"Soliman","year":"2011","journal-title":"Turk J Parasitol"},{"issue":"3","key":"2022030221285293700_bib141","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0022149X00006052","article-title":"Efficacy of avermectins against Trichinella spiralis in mice","volume":"53","author":"Campbell","year":"1979","journal-title":"J Helminthol"},{"issue":"4","key":"2022030221285293700_bib142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","article-title":"Scabies in the developing world\u2014its prevalence, complications, and management","volume":"18","author":"Hay","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2022030221285293700_bib143","first-page":"34","article-title":"Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin","volume":"83","author":"Lawrence","year":"2005","journal-title":"Bull World Health Org"},{"issue":"3","key":"2022030221285293700_bib144","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdv.12099","article-title":"Scabies increased the risk of chronic kidney disease: a 5-year follow-up study","volume":"28","author":"Chung","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2022030221285293700_bib145","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1371\/journal.pntd.0000756","article-title":"A tractable experimental model for study of human and animal scabies","volume":"4","author":"Mounsey","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2022030221285293700_bib146","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.135.6.651","article-title":"Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies","volume":"135","author":"Chouela","year":"1999","journal-title":"Arch Dermatol"},{"issue":"7","key":"2022030221285293700_bib147","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies endemic communities","volume":"145","author":"Mounsey","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"2022030221285293700_bib148","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022030221285293700_bib149","first-page":"563","article-title":"Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population","volume":"82","author":"Heukelbach","year":"2004","journal-title":"Bull World Health Org"},{"key":"2022030221285293700_bib150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fcimb.2019.00474","article-title":"Where are we with human lice? A review of the current state of knowledge","volume":"9","author":"Amanzougaghene","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2022030221285293700_bib151","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0065-308X(08)60493-5","article-title":"Human lice and their management","volume":"36","author":"Burgess","year":"1995","journal-title":"Adv Parasitol"},{"issue":"10","key":"2022030221285293700_bib152","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/archdischild-2011-300791","article-title":"Pediculosis causing iron deficiency anaemia in school children","volume":"96","author":"Burke","year":"2011","journal-title":"Arch Dis Child"},{"issue":"1","key":"2022030221285293700_bib153","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2133.2005.06591.x","article-title":"Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil","volume":"153","author":"Heukelbach","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"2022030221285293700_bib154","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaad.2019.05.110","article-title":"Ectoparasites","volume":"82","author":"Coates","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2022030221285293700_bib155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa0905471","article-title":"Oral ivermectin versus malathion lotion for difficult-to-treat head lice","volume":"362","author":"Chosidow","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2022030221285293700_bib156","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2471\/BLT.08.051656","article-title":"Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial","volume":"88","author":"Pilger","year":"2010","journal-title":"Bull World Health Org"},{"issue":"5","key":"2022030221285293700_bib157","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/dth.12144","article-title":"Assessment of topical versus oral ivermectin as a treatment for head lice: topical versus oral ivermectin for head lice","volume":"27","author":"Ahmad","year":"2014","journal-title":"Dermatol Ther"},{"issue":"11","key":"2022030221285293700_bib158","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/INF.0b013e3181e63f5f","article-title":"Oral ivermectin for treatment of pediculosis capitis","volume":"29","author":"Ameen","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2022030221285293700_bib159","first-page":"985","article-title":"Oral ivermectin for head lice: a comparison with 0.5% topical malathion lotion: oral ivermectin vs. malathion lotion for head lice","volume":"8","author":"Nofal","year":"2010","journal-title":"JDDG J Dtsch Dermatol Ges"},{"issue":"9","key":"2022030221285293700_bib160","doi-asserted-by":"crossref","first-page":"e0006825","DOI":"10.1371\/journal.pntd.0006825","article-title":"Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands","volume":"12","author":"Coscione","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2022030221285293700_bib161","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3347\/kjp.2019.57.5.499","article-title":"Prevalence and alternative treatment of head lice infestation in rural Thailand: a community-based study","volume":"57","author":"Singhasivanon","year":"2019","journal-title":"Korean J Parasitol"},{"issue":"6","key":"2022030221285293700_bib162","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijantimicag.2016.07.014","article-title":"Assessment of oral ivermectin versus shampoo in the treatment of pediculosis (head lice infestation) in rural areas of Sine-Saloum, Senegal.","volume":"48","author":"Leulmi","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2022030221285293700_bib163","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijantimicag.2018.07.005","article-title":"Mutations in GluCl associated with field ivermectin-resistant head lice from Senegal","volume":"52","author":"Amanzougaghene","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2022030221285293700_bib164","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1086\/499279","article-title":"Oral ivermectin in the treatment of body lice","volume":"193","author":"Foucault","year":"2006","journal-title":"J Infect Dis"},{"issue":"9","key":"2022030221285293700_bib165","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jdv.14420","article-title":"European guideline for the management of pediculosis pubis","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"2022030221285293700_bib166","doi-asserted-by":"crossref","first-page":"e1007569","DOI":"10.1371\/journal.pgen.1007569","article-title":"Complexin in ivermectin resistance in body lice","volume":"14","author":"Amanzougaghene","year":"2018","journal-title":"PLoS Genet"},{"issue":"11","key":"2022030221285293700_bib167","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1365-4632.2008.04059.x","article-title":"Impact of ivermectin drug combinations on Pediculus humanus capitis infestation in primary schoolchildren of south Indian rural villages","volume":"48","author":"Munirathinam","year":"2009","journal-title":"Int J Dermatol"},{"issue":"8","key":"2022030221285293700_bib168","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/S0074-02762004000800015","article-title":"Therapy of tungiasis: a double-blinded randomized controlled trial with oral ivermectin","volume":"99","author":"Heukelbach","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"2022030221285293700_bib169","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0103-64402004000100015","article-title":"Oral myiasis treated with ivermectin: case report","volume":"15","author":"Shinohara","year":"2004","journal-title":"Braz Dent J"},{"issue":"6","key":"2022030221285293700_bib170","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/507038","article-title":"Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax","volume":"43","author":"Osorio","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2022030221285293700_bib171","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jemermed.2013.05.014","article-title":"Ivermectin causes Cimex lectularius (bedbug) morbidity and mortality","volume":"45","author":"Sheele","year":"2013","journal-title":"J Emerg Med"},{"key":"2022030221285293700_bib172","first-page":"524","article-title":"Susceptibility status of bedbugs (Hemiptera: Cimicidae) against pyrethroid and organophosphate insecticides in Dar es Salaam, Tanzania","volume":"57(2)","author":"Baraka","year":"2020","journal-title":"J Med Entomol"},{"key":"2022030221285293700_bib173","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13071-017-2232-3","article-title":"Insecticide resistance and resistance mechanisms in bed bugs, Cimex spp. (Hemiptera: Cimicidae)","volume":"10","author":"Dang","year":"2017","journal-title":"Parasit Vectors"},{"issue":"1","key":"2022030221285293700_bib174","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jamadermatol.2013.7688","article-title":"Severe demodex folliculorum\u2013associated oculocutaneous rosacea in a girl successfully treated with ivermectin","volume":"150","author":"Brown","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2022030221285293700_bib175","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijid.2012.11.022","article-title":"Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum","volume":"17","author":"Salem","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"6","key":"2022030221285293700_bib176","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/bjd.12850","article-title":"Human demodicosis: revisit and a proposed classification","volume":"170","author":"Chen","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/3\/201\/42685843\/trab114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/3\/201\/42685843\/trab114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T21:31:32Z","timestamp":1646256692000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/116\/3\/201\/6330149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":176,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,29]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trab114","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2021,7,29]]}}}